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Abstract
Maintenance of neuronal function depends on the delivery of oxygen and glucose through changes in blood flow that are
linked to the level of ongoing neuronal and glial activity, yet the underlying mechanisms remain unclear. Using transgenic
mice expressing the light-activated cation channel channelrhodopsin-2 in deep layer pyramidal neurons, we report that
changes in intrinsic optical signals and blood flow can be evoked by activation of a subset of channelrhodopsin-2-
expressing neurons in the sensorimotor cortex. We have combined imaging and pharmacology to examine the importance
of glutamatergic synaptic transmission in this form of neurovascular coupling. Blockade of ionotropic glutamate receptors
with the antagonists CNQX and MK801 significantly reduced forepaw-evoked hemodynamic responses, yet resulted in no
significant reduction of channelrhodopsin-evoked hemodynamic responses, suggesting that stimulus-dependent coupling
of neuronal activity to blood flow can be independent of local excitatory synaptic transmission. Together, these results
indicate that channelrhodopsin-2 activation of sensorimotor excitatory neurons produces changes in intrinsic optical signals
and blood flow that can occur under conditions where synaptic activation of neurons or other cells through ionotropic
glutamate receptors would be blocked.
Citation: Scott NA, Murphy TH (2012) Hemodynamic Responses Evoked by Neuronal Stimulation via Channelrhodopsin-2 Can Be Independent of Intracortical
Glutamatergic Synaptic Transmission. PLoS ONE 7(1): e29859. doi:10.1371/journal.pone.0029859
Editor: Fabien Tell, The Research Center of Neurobiology-Neurophysiology of Marseille, France
Received October 19, 2011; Accepted December 5, 2011; Published January 10, 2012
Copyright:  2012 Scott, Murphy. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants to THM (MOP49586) from Canadian Institutes of Health Research, Canadian Stroke Network and the Heart and
Stroke Foundation of BC and the Yukon. NAS was supported by studentships from Natural Sciences and Engineering Research Council and the Canadian Institutes
of Health Research Strategic Training Program in Neurobiology and Behaviour. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: thmurphy@interchange.ubc.ca
Introduction
The link between neural activity and cerebral blood flow –
neurovascular coupling – appears from the outset to be clearly
delineated: initial energy demand in neurons drives localized
oxygen consumption and the subsequent influx of oxygenated
blood [1,2]. While functional imaging techniques are predicated
on this facile assumption, caveats must be placed when using
changes in blood oxygenation and flow as proxies of neuronal
activation, as it is not always clear which cell types – excitatory
neurons, inhibitory interneurons, or glial cells – can initiate
neurovascular coupling. It remains further unclear which
pathways underlie the coupling of activity to changes in blood
flow, with strong proponents both for neuronal and astrocytic
intermediaries [1,2].
Thus far, studies of neurovascular coupling have been limited
by the inability to selectively initiate neuronal activity. In this
study, we have investigated whether direct in vivo stimulation of
excitatory neocortical neurons is sufficient to produce measurable
changes in hemodynamic signals and blood flow. To achieve this,
we have used channelrhodopsin-2 (ChR2) transgenic mice (B6.Cg-
Tg(Thy1-COP4/EYFP)18Gfng/J) that express a photoactivatable
non-specific cationic channel [3,4], allowing us to selectively
activate regions of the sensorimotor cortex [5]. These mice express
ChR2 in deep layer cortical pyramidal neurons under the Thy-1
promoter with a pattern that closely resembles other animal lines
with expression in predominantly cortical layer 5B neurons [5,6].
While it has been recently demonstrated that activation of ChR2
expressing excitatory neurons evokes changes in the fMRI BOLD
signal [7,8], the underlying physiology and direct relationship of
these responses to blood flow has not been investigated in detail.
Furthermore, previous work has shown that intracortical micro-
stimulation using electrodes can be used to examine regional
connectivity by monitoring hemodynamic responses with fMRI
[9,10]. To this end, we have coupled pharmacology with selective
neuronal activation to examine the role of glutamatergic signaling
in the production of hemodynamic responses. Specifically, we have
addressed whether activation of deep layer neurons alone is
sufficient to initiate hemodynamic responses. Furthermore, using
pharmacology we have examined the roles of ionotropic glutamate
receptors and Group I metabotropic glutamate receptors in the
production of ChR2-evoked hemodynamic responses. Our results
indicate that hemodynamic responses can be initiated by activity
within deep layer pyramidal neurons without the involvement of
synaptically activated neurons or glia through ionotropic gluta-
mate receptors.
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Ethics statement
All animal procedures were performed in accordance with and
approved by the University of British Columbia Animal Care
Committee protocols (protocol #A09-0665) in accordance with
the Canadian Council for Animal Care guidelines.
Animals and surgery
Adult ChR2 transgenic mice (line 18, stock 007612, strain
B6.Cg-Tg (Thy1-COP4/EYFP)18Gfng/J; the Jackson Laborato-
ry, Bar Harbor, ME) were initially anaesthetized with isoflurane
(4% in air for induction, 1.5% for surgery) and craniectomized
over the right sensorimotor cortex as previously described [11]. In
experiments involving no cortical application of pharmacological
agents, the exposed brain was covered with 1–1.5% agarose (Type
3-A Sigma; A9793) dissolved in a HEPES-buffered (pH 7.3)
physiological salt solution (135 mM NaCl, 5.4 mM KCL, 1 mM
MgCl2, 1.8 mM CaCl2, and 5 mM HEPES) and sealed with a
glass coverslip. Following surgery, isoflurane was discontinued and
anaesthesia was maintained with ketamine (20 mg/ml)/xylazine
(1 mg/ml), administered as necessary to maintain a constant level
of anaesthesia; animals were supplemented with a mixture of
oxygen in air. Temperature (3760.5uC) was maintained through-
out the experiment using a feedback-regulated heating pad
monitored by a rectal thermometer. Heart rate and blood oxygen
saturation were monitored (Starr Life Sciences pulse oximeter,
Oakmont, PA).
Optical imaging and stimulation
For photostimulation of ChR2-expressing neurons, we used a
473 nm photoactivation laser (CrystaLaser BCL-473-050, Reno,
NV) as previously described [5]. For forepaw electrical stimula-
tion, a train of pulses was delivered by a stimulus isolator (World
Precision Instruments, Sarasota, FL) through two 30-gauge
needles inserted subcutaneously into the left forepaw. Our stimulus
protocol (1.5 mA, 3 Hz, 1–4 s) was adopted from the literature
[12].
To visualize the cortex and vasculature, the surface of the brain
was illuminated with green LEDs, while red LEDs (centred at
635 nm) were used for intrinsic optical imaging (IOS), with the
depth of focus set to approximately 250 mmt ob l u rt h e
contribution of surface blood vessels (set-up shown in
Figure 1A). Intrinsic optical signal imaging allows the measure-
ment of oximetric signals through the back-reflection of light
[13]; at the wavelength used in the present study, the
measurements comprise both changes in the oxygenation state
of hemoglobin and blood volume [14]. All images were captured
with a CCD Dalsa 1M60 camera, with image acquisition
performed using EPIX XCAP software (Buffalo Grove, IL;
v2.2) with an E1DB frame grabber (EPIX). For IOS, each run
consisted of twenty trials separated by a 45 s intertrial interval to
allow responses to return to baseline. For each trial, 50 frames
over 5 s were obtained at 10 Hz. These images were summed
over repeated trials, from which the percentage change in
635 nm reflectance (DI/I %) was calculated at 32-bit resolution
by dividing the difference between pre- and post-stimulation
images by pre-stimulation images using a custom-written ImageJ
(NIH, Bethesda, MD) plugin [15]. Due to the oversaturation
caused by the 473 nm stimulation laser, these frames were
blanked; thus, blanks in the displayed temporal profiles of IOS
responses reflect stimulus artifacts. The terms ‘changes in 635 nm
reflectance’ and IOS responses are used interchangeably
throughout the text.
To assess blood flow, we used laser speckle contrast imaging,
which capitalizes on the flow of blood cells that causes blurring of
interference patterns created by coherent light illumination
[16,17]. Illumination was provided by a 784 nm 32 mW Stock-
erYale SNF-XXX_885S-35 laser (Stocker & Yale, Salem, NH)
with an Edmund anamorphic beam expander T47274 (Edmund
Optics, Barrington, NJ) held on a micromanipulator at a 30u angle
(Figure 1A). A polarizer filter was used to modulate laser output.
As with the IOS data, laser speckle images were saturated during
periods of 473 nm laser stimulation and were blanked accordingly.
However, in later experiments, a 715 nm lowpass filter was used to
prevent light from the 473 nm laser from entering the camera.
Data with and without the lowpass filter were included in the
present study; thus, some figures do not have a stimulus artifact.
For stimulation trials, each run consisted of twenty trials separated
by a 45 s intertrial period, with 100 images collected over 10 s
(10 Hz) using 10 ms exposure. Spatial laser speckle contrast was
calculated using ImageJ (NIH) as described previously [18] [11].
Here, we additionally took the inverse square of the laser speckle
contrast as an approximation of blood flow [19]. Thus, it is
important to note that with this calculation, an increase in speckle
contrast (lighter values) reflects increased blood flow. The terms
changes in blood flow and ‘speckle contrast’ are used interchange-
ably throughout the text.
Imaging analysis
For IOS and laser speckle data, temporal profiles were derived
from ROIs (1006100 pixels) centered on the site of laser
activation; profiles were smoothed (adjacent averaging) over 1 s
prior to identifying the peak (defined as the first peak following the
end of stimulation). Images for figures were Gaussian filtered
(radius in pixels=3 for IOS, 8 for speckle contrast) and speckle
contrast images were averaged over 10 frames in ImageJ.
EEG
Electrophysiological data were obtained in parallel with imaging
sessions to compare stimulation-evoked EEG responses to
hemodynamic changes. We placed a Teflon-coated silver wire
on the surface of the cortex, with the reference electrode placed
subcutaneously in the nose. The signal was amplified and filtered
(0.1–1000 Hz) using a differential AC amplifier (Model 1700, A-M
Systems, Sequim, WA), with data collected using Clampex 9.2
(Molecular Devices, Inc., Sunnyvale, CA). Records were normal-
ized and averaged using Clampfit 9.2 (Molecular Devices, Inc.,
Sunnyvale, CA). For spontaneous data, power spectrum analysis
was performed using Clampfit 9.2. Frequency band analysis was
performed to calculate the percentage of total power for the
following defined frequency bands (Delta=0.3–3 Hz; theta=3–
5 Hz; alpha=8–15 Hz; beta=15–30 Hz; and gamma 30–80 Hz).
Pharmacology
To block local NMDA and AMPA receptors, we directly co-
applied the ionotropic glutamate receptor antagonists CNQX
(Sigma-Aldrich Co., Oakville, ON) and MK801 (Sigma-Aldrich
Co.) to the surface of the intact dura (no agarose was present), at
concentrations that we have previously demonstrated as sufficient
to block sensory stimulation-evoked IOS maps (4.5 mM and
0.3 mM, respectively [20], both in physiological saline solution);
responses were found to be similar whether or not the dura was
present. For our experimental procedures, animals were pre-
imaged, incubated for a minimum time of 30 min with CNQX/
MK801 and post-imaged. Antagonists were reapplied to the cortex
following each imaging run. To inhibit the Group I metabotropic
receptor mGluR5, animals were pre-imaged, injected i.p. with
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imaged after 20 min (for ChR2 stimulation experiments) and
40 min (for electrical forepaw stimulation experiments) in the same
animals.
Statistics
All statistics were performed in GraphPad Prism (GraphPad
Software, Inc.). All t-tests performed are two-tailed. All ANOVA
are two-way repeated measures, unless otherwise noted. Data are
reported as mean 6 SEM; n=number of animals. Statistical
significance on all figures uses the following convention: * p.0.05,
** p.0.01, *** p.0.001.
Results
To assess whether activation of subsets of ChR2-expressing
neurons were sufficient to produce observable hemodynamic
responses, we employed intrinsic optical signal (IOS) imaging
[14,21] and laser speckle imaging [16,17] to observe signals that
reflect changes in oxygenation and blood flow in vivo, respectively.
Local targeting of blue collimated laser light (473 nm) through a
coverslip-enclosed craniotomy allowed us to selectively stimulate
ChR2-expressing neurons (Figure 1A) in the sensorimotor cortex
with a high degree of spatial precision [5]. To compare these
results with sensory stimulation, mice were given a brief shock to
their forepaw. Successful activation by ChR2 stimulation was
confirmed by a light-evoked EEG response (Figure 1B), while
parallel local changes in (apparent) oxygenation were assessed by
measuring changes in the reflectance of 635 nm light, a
wavelength that is sensitive to intrinsic optical signals (IOS) of
oxyhemoglobin and deoxyhemoglobin (Figure 1C). We observed
relative changes in IOS upon presentation of 1000 ms (n=23
mice) trains of blue light stimulation (100 Hz stimulation, 5 ms
pulse duration) that paralleled responses evoked by forepaw
(sensory) stimulation (1000 ms, 3 Hz, 300 ms pulse duration) in
their time course (n=12 mice) (Figure 1E). IOS responses could be
reliably evoked with as little as a single 5 ms blue light pulse (not
shown). Both ChR2-evoked changes in EEG and IOS could also
be evoked through a thinned skull preparation (data not shown) at
amplitudes comparable to those evoked in craniectomized animals
[22]. To investigate whether functional hyperemia (elevated blood
flow) were associated with these apparent changes in oxygenation
(IOS signals), we used laser speckle contrast imaging at 785 nm to
monitor changes in blood flow over large areas (Figure 1D). We
observed changes in normalized speckle contrast upon presenta-
tion of 1000 ms (n=13) trains of ChR2 stimulation, indicating
that ChR2 stimulation could evoke changes in blood flow that
were of equal or greater magnitude to those evoked by 4 s of
forepaw stimulation (as 1 s of forepaw stimulation did not produce
consistent responses, 4 s were used) (n=12) (Figure 1F). Changes
in speckle contrast could be reliably evoked with a 10 ms train of
ChR2 stimulation (not shown). For both IOS and speckle contrast
responses, temporal profiles were blanked during periods of laser
stimulation.
To examine whether ChR2-evoked IOS and blood flow
responses differ in their spatial extent when measured in the same
animals, we compared the peak amplitude of responses at
increasing distances (500 mm increments) from the centre of
activation (0 mm), which we defined as the area of ChR2 laser
stimulation (Figure 1G). Laser speckle and IOS time courses were
smoothed (adjacent averaging) over 1 s prior to identifying the
peak (see Methods). The peak amplitudes at each distance were
normalized within each animal to peak amplitude at the site of
stimulation prior to averaging over animals (n=6). For ChR2-
evoked hemodynamic responses, our data indicate that IOS
responses were localized to the site of laser activation, while
changes in speckle contrast were significantly more broader
(Figure 1G; F(1,123)=43.71, p,0.0001, 2-way ANOVA, n=6).
There was a significant difference between the spatial extents of
IOS and speckle contrast responses at distances greater than
1000 mm (all p,0.001, post-hoc Bonferroni). A similar effect was
observed when we compared the spatial extent of sensory
(forepaw) stimulation-evoked IOS and speckle contrast responses
measured in the same animals (Figure 1H; F(1,64)=11.59,
p=0.0012, 2-way ANOVA, n=4), with significant differences in
the spatial extent of IOS and speckle contrast responses observed
at distances of 500 mm and 1000 mm (both p,0.05).
ChR2 stimulation in ChR2-negative mice produced no
observable change in EEG, IOS or speckle contrast signals,
indicating that these effects are specific to mice expressing
channelrhodopsin (Figure S1A–C). For these control experiments,
negative littermates of ChR2-positive animals were used (n=2).
Responses in negative animals were similar to those observed in
dead ChR2-positive animals (Figure S1D, S1E, n=2).
In a small number of animals, stimulation experiments were
performed under different anaesthesic conditions in order to
determine whether the observed hemodynamic responses were
specific to ketamine anaesthesia. While IOS responses could be
evoked from ChR2 stimulation under 1.5% isoflurane anaesthesia
in preliminary work, the evoked changes in speckle contrast were
smaller than those obtained under ketamine xylazine anaesthesia
(n=2). Thus for the present study, ketamine xylazine anaesthesia
was preferred over isoflurane as greater changes in IOS and
speckle contrast could be more reliably elicited and this regime
permitted comparisons to previous motor mapping work with
ChR2 [5].
To test for possible negative effects of ChR2 laser stimulation on
the cortex, we focused the laser on the forepaw sensory cortex map
and examined the amplitudes of sensory-evoked IOS maps before
and after 20 trials of light stimulation of ChR2. No differences in
temporal profiles (Figure S2A; F(1,200)=2.37, p=0.1253) and
peak amplitudes of evoked sensory maps before (DI/I
Figure 1. IOS and laser speckle imaging reveals ChR2 and sensory (forepaw) evoked hemodynamic responses. A, Schematic of
experimental set-up. Responses to ChR2 stimulation (473 laser activation) and electrical sensory stimulation were recorded via IOS imaging (635 nm)
and laser speckle imaging (785 nm). B, Averaged EEG responses (20 trials) to 100 ms and 1000 ms of ChR2 stimulation in a representative animal. C,
left: Green light image of the cortical surface. Peak IOS response (averaged over 1 s from peak) to 1 s of ChR2 stimulation (middle) and 1 s of sensory
stimulation (right). D, Maximum normalized laser speckle contrast response (averaged over 1 s at peak) to no stimulation (left), 1 s of ChR2
stimulation (middle) and 4 s of sensory stimulation (right) in the same animal. C,D Data shown are averaged 20 trials from a representative animal. E,
Temporal profiles of IOS responses evoked by 1 s of ChR2 stimulation (n=23) compared to 1 s of sensory stimulation (n=12). F, Temporal profiles of
laser speckle responses evoked by ChR2 stimulus train durations of 1 s (n=13) compared to 4 s of sensory stimulation (n=12). B,E–F Grey and black
bars represent onset and duration of stimulation. Blanked data in temporal profiles reflect laser stimulus artifact. The peak amplitudes of ChR2-
evoked IOS and speckle contrast responses were compared as a function of distance from the centre of laser activation (G). The spatial extents
differed within animals at distances greater than 1000 mm (n=6, both p,0.001, paired t-test). H, A similar effect was observed in sensory-evoked IOS
and speckle contrast responses at distances of 500 and 1000 mm (n=4, both p,0.05, paired t-test). Error bars represent SEM.
doi:10.1371/journal.pone.0029859.g001
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lation were found (Figure S2B; n=5, p=0.3463, paired t-test). In
order to determine the effect of ChR2 stimulation on resting
neural activity, we examined the power spectra of spontaneous
EEG activity recorded (10 min) immediately prior to and
following 20 trials of ChR2 stimulation (100 Hz, 1 s duration).
As shown in Figure S2C, ChR2 stimulation had no significant
effect (F(1,1330)=0.04, p=0.8400, n=6) overall, nor when the
data were compared by frequency band (Figure S2D; Bonferroni
post-test, all bands p.0.05). Likewise, ChR2 stimulation had no
significant effect on either heart rate or oxygen saturation
measurements (Bonferroni post-test, both p.0.05) during 20 trials
of ChR2 stimulation in comparison to measurements obtained
prior to ChR2 stimulation (Figure S2E; repeated measures
ANOVA, F(1,6)=0.01, p=0.9384).
To determine whether ChR2-evoked hemodynamic responses
were graded according to stimulus duration, as has been observed
for sensation-evoked hemodynamic responses [23] and for ChR2-
evoked BOLD responses [8], we examined the effect of increasing
stimulus train duration on peak changes in IOS and speckle
contrast (Figure 2). We found that maximal changes in speckle
contrast were significantly greater (Figure 2A,B; p=0.0294, ratio
t-test of log-transformed values, n=7) when stimulated with
1000 ms trains (5.561.3%, n=7) compared to 100 ms trains
(2.560.5%, n=7). Correspondingly, evoked changes in IOS were
greater (Figure 2C,D; p=0.0012, paired t-test, n=7) in response
to 1000 ms stimulation (DI/I 20.2560.04%, n=7) than to
100 ms stimulation (DI/I 20.0660.01%, n=7). Maximal changes
in IOS (635 nm reflectance) peaked at 1.360.2 s after stimulus
onset (100 ms ChR2 stimulus train), while maximal changes in
speckle contrast peaked at 1.160.3 s (paired t-test, p=0.7188,
n=6, one animal was excluded as the peak occurred during the
stimulus artifact).
Postsynaptic activity has long been considered to be a primary
determinant of neurovascular coupling [24]. To test whether
ionotropic excitatory synaptic transmission were required for the
production of hemodynamic responses, we first measured the
effects of the AMPA receptor antagonist CNQX and the NMDA
receptor antagonist MK801 on the changes in IOS evoked both by
forepaw stimulation and direct activation of cortical neurons
through ChR2 stimulation (Figure 3A). Following cortical
incubation with CNQX/MK801, the IOS response evoked by
1 s of electrical forepaw stimulation in a representative animal was
blocked, while the IOS response evoked by 1 s of ChR2
Figure 2. Effect of varying ChR2 stimulus train duration on evoked hemodynamic responses. A, Temporal profiles of laser speckle
responses evoked by 100 ms (grey, n=7) and 1000 ms of ChR2 stimulation (black, n=7). B, Peak amplitudes of temporal profiles in (A), compared
within the same animals (p=0.0294, n=7). C, Temporal profiles of IOS responses evoked by 100 ms (grey, n=7) and 1000 ms of ChR2 stimulation
(black, n=7). D, Peak amplitudes of temporal profiles in (C), compared within the same animals (p=0.0012, n=7).
doi:10.1371/journal.pone.0029859.g002
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evoked IOS responses obtained from temporal profiles in
Figure 3C were significantly reduced following incubation with
CNQX/MK801 (Figure 3E; paired t-test, p=0.0009, n=7), while
no significant reduction was observed for peak changes in ChR2-
evoked IOS responses obtained from temporal profiles in
Figure 3D (Figure 3E; paired t-test, p=0.9358, n=7).
To investigate the effect of intracortical ionotropic excitatory
synaptic transmission blockade on ChR2-evoked changes in blood
flow, we examined changes in speckle contrast before and after
incubation with CNQX/MK801 (Figure 4). We observed that
channelrhodopsin-evoked laser speckle changes were intact
following the blockade of ionotropic intracortical synaptic
transmission in 5 animals (Figure 4A), with no significant
difference observed in the peak speckle contrast changes
(Figure 4B; paired t-test, p=0.0789, n=5). As expected, forepaw
sensory-evoked changes in speckle contrast were significantly
decreased upon incubation with CNQX/MK801 (Figure 4C;
F(1,700)=155.67; repeated measures ANOVA; p,0.0001, n=8),
with a significant reduction in peak speckle contrast (Figure 4D;
paired t-test, p=0.0144, n=8). These results indicate that
activation of neurons through ChR2 leads to increases in blood
flow that can occur independently of ionotropic glutamatergic
intracortical synaptic transmission.
To determine whether cortical incubation of CNQX and
MK801 permitted diffusion of the antagonists to lower cortical
layers, we combined antagonist incubation with laminar probe
(NeuroNexus Technologies, Inc., Ann Arbor, MI) recordings at
depths up to 800 mm in the forepaw sensory region. We confirmed
decreases in forepaw sensory-evoked local field potential ampli-
tude at all recorded depths. LFP deflections evoked by forepaw
stimulation were not significantly larger than fluctuations recorded
in the absence of stimulation before CNQX and MK801
application (RM-ANOVA, n=7 mice; Harrison and Murphy
unpublished observations).
In vitro experiments have suggested that the astrocytic Group I
metabotropic glutamate receptor mGluR5 couples presynaptic
release of glutamate to changes in blood flow [25], however other
in vivo results in rodent somatosensory cortex suggest no
significant effect [26]. Our results with ChR2 stimulation indicate
only a partial reduction in ChR2-evoked speckle contrast following
a 20 min incubation of the mGluR5 antagonist MPEP (Figure 5A;
repeated measures ANOVA, F(1,700)=59.62, p,0.0001, n=8).
The peak ChR2-evoked speckle contrast was significantly reduced
Figure 3. Blockade of synaptic transmission by CNQX and MK801 inhibits forepaw stimulation responses but not ChR2. A, left: Pre-
antagonist IOS responses to sensory stimulation (yellow, indicated by yellow arrow) and ChR2 stimulation (green, indicated by green arrow)
thresholded to 50% of maximum and superimposed on an image of the cortical surface. Right: Temporal evolution of IOS responses to 1 s of sensory
stimulation (upper) and ChR2 stimulation (lower). B, left: Post-antagonist IOS response to sensory stimulation is inhibited (yellow arrow indicates pre-
antagonist map location), while the IOS response to ChR2 stimulation is preserved (green, indicated by green arrow). Right: Temporal evolution of IOS
responses to 1 s of sensory stimulation (upper) and ChR2 stimulation (lower). A,B Shown are the averaged results of 20 trials from a representative
animal; blanked data at 0 s represents stimulus artifact. C, Temporal profiles of IOS responses to 1 s of sensory stimulation before and after CNQX/
MK801 incubation (n=7); responses are displayed until pre-CNQX/MK801 responses return to baseline. D, Temporal profiles of IOS responses to 1 s of
ChR2 stimulation before and after CNQX/MK801 incubation (n=7); blanked data indicate laser stimulus artifact. C,D Stimulus onset denoted by
vertical dotted line. E, Peak amplitudes in sensory-evoked IOS responses were significantly reduced following antagonist incubation (paired t-test,
p=0.0009) while peak ChR2-evoked IOS responses were not (paired t-test, p=0.9358). Error bars represent SEM.
doi:10.1371/journal.pone.0029859.g003
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mean of 6.361.4% to a post-MPEP mean of 3.460.9%, resulting
in a mean reduction of 33.7620.8% when compared over all 8
animals. Half of the animals used for ChR2 stimulation were also
examined for the effect of MPEP incubation on sensory-evoked
speckle contrast, measured at 40 min post-MPEP incubation.
MPEP incubation resulted in a significant reduction in forepaw
sensory-evoked speckle contrast (Figure 5C; F(1,300)=81.82,
p,0001; two-way repeated measures ANOVA, n=4), with a
significant (Figure 5D; p=0.0155, t-test, n=4) reduction in peak
speckle contrast observed, from a pre-drug mean of 3.560.9% to a
post-drug mean of 2.360.9%, resulting in a mean reduction of
41.9767.40% overall. To test whether this reduction were
attributable to the injection itself, we compared ChR2-evoked
speckle contrast before and after injection of the saline vehicle
alone. No significant difference was observed (Figure 5 E,F; paired
t-test, p=0.8211, n=3) from a pre-vehicle mean of 4.762.0% to a
post-vehicle mean of 4.961.3%.
To determine whether there were non-specific effects of MPEP,
we examined its effect on unstimulated baseline EEG (Figure
S3A,B). We examined 10 min of spontaneous EEG collected
before and after MPEP injection (up to 20 min post-injection). In 4
animals, power spectra amplitudes were compared by frequency
band (Figure S3B) before and after MPEP incubation, and no
significant effect of MPEP was observed (Bonferroni post-test, all
p.0.05, n=4). In order to determine whether the observed
reductions in blood flow responses upon MPEP incubation could
be attributable to changes in underlying physiology, we compared
heart rate and oxygen saturation recordings prior to MPEP
incubation and at 0 min and 10 min post-MPEP incubation. No
significant effect of drug incubation was observed (Figure S3C;
repeated measures ANOVA, p=0.2308, F(2,8)=1.77, n=3), nor
when all post-drug time points were compared to pre-drug
averages (all p,0.05 for oxygen saturation and heart rate, n=3).
Discussion
We have demonstrated that stimulation of ChR2-expressing
pyramidal neurons is sufficient to evoke changes in oxygenation and
blood flow and further, that production of these hemodynamic
signals is not sensitive to reduction of intracortical excitatory
synaptic transmission through ionotropic glutamate receptors.
Figure 4. ChR2-evoked blood flow is not inhibited by blocking intracortical ionotropic glutamatergic synaptic transmission by
CNQX/MK801. A, Temporal profiles of laser speckle responses evoked by 1 s of ChR2 stimulation before and after antagonist incubation. B,
Comparison of peak amplitudes (averaged over 1 s) in laser speckle contrast responses in (A) before and after antagonist incubation. No significant
difference was observed (n=5, paired t-test, p=0.0789). C, Temporal profiles of laser speckle responses evoked by forepaw sensory stimulation
before and after antagonist incubation. D, Comparison of peak amplitudes (averaged over 1 s) in laser speckle contrast responses in (C) before and
after antagonist incubation. A significant difference was observed (n=8, paired t-test, p=0.0144). Error bars represent SEM.
doi:10.1371/journal.pone.0029859.g004
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of neurovascular coupling
The predominant view is that brain activity dependent changes
in oxygenation [27,28] and cerebral blood flow [29,30] are
strongly coupled to local glutamate-dependent postsynaptic
neuronal activity, both in the cortex and cerebellum. To date,
the only exceptions to this have been observed in the olfactory
bulb, where changes in IOS [20] and blood flow [31] were evoked
in the absence of ionotropic glutamate receptor activation.
However, as argued by Attwell et al. (2010) [1], much of the
pharmacological and electrophysiological support ascribed to-
wards ionotropic glutamate receptor dependency applies equally
to glutamate-activated astrocytic pathways. Indeed, one of the key
pieces of evidence [32] in favour of postsynaptic neuronal signaling
Figure 5. ChR2-evoked and sensory-evoked changes in blood flow are partially reduced by the mGluR5 antagonist MPEP. A,
Temporal profiles of laser speckle responses evoked by 1 s of ChR2 stimulation before and after antagonist incubation. B, Comparison of peak
amplitudes (averaged over 1 s) in laser speckle contrast responses in (A) before and after antagonist incubation. A significant difference was observed
(n=8, paired t-test, p=0.0251). C, Temporal profiles of laser speckle responses evoked by sensory stimulation before and after antagonist incubation.
D, Comparison of peak amplitudes (averaged over 1 s) in laser speckle contrast responses in (C) before and after antagonist incubation. A significant
difference was observed (n=4, paired t-test, p=0.0155). E, Temporal profiles of laser speckle responses evoked by ChR2 stimulation before and after
injection of saline vehicle. F, Comparison of peak amplitudes (averaged over 1 s) in laser speckle contrast responses in (E) before and after saline
injection. No significant difference was observed (n=3, paired t-test, p=0.8211). Error bars represent SEM.
doi:10.1371/journal.pone.0029859.g005
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intracortical processing) with changes in blood flow – could be
similarly correlated with astrocyte activation. However, within the
in vivo situation it would be difficult to extricate glial cells from the
circuits of the brain [2].
The fact that ChR2-evoked changes in blood flow showed a
trend towards increased magnitude upon blockade of ionotropic
glutamate receptors is suggestive of interneuron-mediated inhibi-
tion through tonic activation of presynaptic GABA-B receptors, as
observed in the olfactory bulb [31,33]; thus, the increased blood
flow we observed could point to enhanced activation of
metabotropic glutamate receptors through elevated presynaptic
release of glutamate. Our results suggest that ChR2-evoked
neuronal activity, as with sensory-evoked activity, is coupled
partially (,34%) to functional hyperemia via an mGluR5-
dependent pathway [25]. Similarly, studies of the olfactory bulb
[31] and cortex [34] have demonstrated a partial role for
presynaptic release of glutamate in triggering hemodynamic
responses via metabotropic glutamate receptors, in particular
mGluR5, while other data suggests no significant role of mGluR5
in rodent somatosensory cortex [26]. Why is the mGluR5 effect on
ChR2-evoked elevation in blood flow only partial? As observed by
[35] in vitro, only a relatively small fraction of astrocytes
consistently responded to ChR2 activation within neurons, a
number that was subsequently reduced upon mGluR5 blockade by
MPEP. Thus, it is possible that the partial reduction we observe
represents the full blockade of mGluR5 receptors, but that the
remainder of the response operates via alternate pathways,
possibly involving astrocytic glutamate uptake transporters [20].
In summary, we have demonstrated the ability to stimulate
changes in oxygenation and blood flow through direct activation of
excitatory cortical neurons. Moreover, we have provided evidence
that neuronal or glial ionotropic glutamate receptors may not need
to be the primary mediators of neurovascular coupling initiated by
direct neuronal activation. However, we acknowledge that our
findings do not preclude alternate mechanisms involving synaptic
activation of intermediary neuronal populations or glia that do not
involve CNQX- or MK-801-sensitive glutamate receptors. Alter-
natively, it is possible that vasoactive agents [36], released as a
consequence of ChR2-initiated action potentials may act upon
nearby capillaries or arterioles to produce changes in dilation and
concomitant changes in blood flow, thus coupling activity in
activated neurons to the surrounding vasculature.
Supporting Information
Figure S1 No channelrhodopsin-evoked hemodynamic
responses are observed in non-channelrhodopsin-ex-
pressing and dead channelrhodopsin-positive animals.
A, (left) Green light image of the cortical surface, peak IOS
response (averaged over 1 s from peak) (middle) and peak
normalized laser speckle contrast response (averaged over 1 s at
peak) (right) to 1 s of ChR2 stimulation; data shown are averaged
20 trials from a representative animal. Temporal profiles of (B)
IOS and (C) laser speckle responses evoked by ChR2 stimulation
for ChR2-negative and ChR2-positive animals. Temporal profiles
of (D) IOS and (E) laser speckle responses evoked by ChR2
stimulation for dead ChR2-positive mice. B–E, Black bars
represent onset and duration of stimulation. Blanked data in
temporal profiles reflect laser stimulus artifact. Error bars
represent SEM, all n=2.
(PDF)
Figure S2 Effect of ChR2 stimulation on spontaneous
EEG activity, sensory-evoked IOS responses and base-
line physiology. A, Temporal profiles of sensory-evoked IOS
responses evoked before (grey) and after (black) 20 trials of ChR2
stimulation, as shown in timeline (above). B, Peak responses of
temporal profiles in (A) before and after ChR2 stimulation. No
significant difference was observed (n=5, p=0.3463, paired t-test).
C, Power spectrum analysis of spontaneous EEG recordings before
(grey) and after (black) 20 trials of ChR2 stimulation. D, Power
spectra in (C) compared by frequency band; bands Alpha-Gamma
are graphed on the right y-axis. C,D n=6, all p.0.05. E, ChR2
stimulation had no significant effect on either mean heart rate and
oxygensaturationmeasurements(Bonferronipost-test,bothp.0.05)
during20trialsofChR2 stimulationincomparisontomeasurements
obtained prior to ChR2 stimulation (repeated measures ANOVA,
F(1,6)=0.01, p=0.9384), although ChR2 did have a significant
effect on the variance of oxygen saturation (p=0.0365).
(PDF)
Figure S3 Effect of MPEP on spontaneous EEG activity
and baseline physiology. A, Power spectrum analysis of
spontaneous EEG recordings before (grey) and after (black) MPEP
injection. B, Power spectra in (A) compared by frequency band;
bands Alpha-Gamma are graphed on the right y-axis. No
significant effect of MPEP incubation was observed for any
frequency band (Bonferroni post-test, all p.0.05, n=4). C, Heart
rate and oxygen saturation recordings prior to MPEP incubation
and at 0 minutes and 10 minutes post-MPEP incubation. No
significant effect of drug incubation was observed (repeated
measures ANOVA, p=0.2308, F(2,8)=1.77, n=3), nor when
all post-drug time points were compared to pre-drug averages (all
p,0.05 for oxygen saturation and heart rate, n=3).
(PDF)
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